Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Eur J Dermatol ; 33(1): 6-11, 2023 Feb 01.
Article in English | MEDLINE | ID: mdl-37154809

ABSTRACT

BACKGROUND: Rosacea prevalence varies worldwide and there is a lack of information in Brazil. OBJECTIVES: To describe the epidemiological profile of rosacea in subjects who consulted in dermatological outpatient clinics in Brazil. MATERIALS & METHODS: A cross-sectional study was conducted in 13 dermatological outpatient clinics across the country. Patients with rosacea diagnosis were eligible for the study according to the investigator's clinical assessment. Clinical, social and demographic data were collected. The overall and regional rosacea prevalence was calculated, and association with baseline characteristics was analysed. RESULTS: A total of 3,184 subjects were enrolled, and rosacea prevalence was 12.7%. The southern region of Brazil presented a higher prevalence, followed by the southeast. The subjects in the rosacea group were older than those without rosacea (52.5 ±14.9 vs. 47.5 ±17.5; p<0.001). Moreover, the rosacea group was associated with Fitzpatrick's phototypes I and II, Caucasian ethnicity, a family history of rosacea, and facial erythema, however, no association with gender was found. The most prevalent clinical sign and clinical subtype in rosacea patients were erythema and erythematotelangiectatic, respectively. CONCLUSION: Rosacea is highly prevalent in Brazil, mostly in the southern region, associated with phototypes I and II and a family history.


Subject(s)
Dermatology , Rosacea , Humans , Brazil/epidemiology , Cross-Sectional Studies , Rosacea/epidemiology , Rosacea/complications , Erythema/complications
2.
Clin Infect Dis ; 77(4): 574-582, 2023 08 22.
Article in English | MEDLINE | ID: mdl-37100061

ABSTRACT

BACKGROUND: Meglumine antimoniate (MA) remains the main treatment for cutaneous leishmaniasis (CL). Uncontrolled studies suggest that intralesional MA (IL-MA) may be noninferior and safer than systemic MA (S-MA). METHODS: Multicenter, randomized, controlled, open-label, phase 3 clinical trial to evaluate the efficacy and toxicity of IL-MA in 3 infiltrations at 14-day intervals compared with S-MA (10-20 mg Sb5+/kg/day, 20 days) for CL, with noninferiority margin of 20%. Primary and secondary outcomes were definitive cure at day 180 and epithelialization rate at day 90 of treatment, respectively. A 2-year follow-up was performed to assess relapses and emergence of mucosal lesions. Adverse events (AEs) were monitored according to the Division of AIDS AE grading system. RESULTS: We evaluated 135 patients. The cure rates (95% confidence interval) for IL-MA and S-MA treatment were, respectively, 82.8% (70.5-91.4) and 67.8% (53.3-78.3) per protocol (PP) and 70.6% (58.3-81.0) and 59.7% (47.0-71.5) per intention to treat (ITT). The epithelialization rates of the IL-MA and S-MA treatment were, respectively, 79.3% (66.6-88 + 8) and 71.2% (57.9-82.2) PP and 69.1% (55.2-78.5) and 64.2% (50.0-74.2) ITT. AEs in the IL-MA and S-MA groups were, respectively, clinical, 45.6% and 80.6%; laboratory, 26.5% and 73.1%; and electrocardiogram, 8.8% and 25.4%. Ten participants in the S-MA group and 1 in the IL-MA group were discontinued due to severe or persistent AEs. CONCLUSIONS: IL-MA provides a similar cure rate and results in less toxicity compared with S-MA and may be used as first-line therapy for CL patients. CLINICAL TRIALS REGISTRATION: REBEC: RBR-6mk5n4.


Subject(s)
Antiprotozoal Agents , Leishmaniasis, Cutaneous , Organometallic Compounds , Humans , Meglumine Antimoniate/therapeutic use , Meglumine Antimoniate/adverse effects , Antiprotozoal Agents/adverse effects , Meglumine/adverse effects , Brazil , Treatment Outcome , Organometallic Compounds/adverse effects , Leishmaniasis, Cutaneous/drug therapy
3.
An Bras Dermatol ; 95(2): 238-240, 2020.
Article in English | MEDLINE | ID: mdl-32146012

ABSTRACT

Some epidermal alterations in measles has been described, such as keratinocytes apoptotic, parakeratosis, giant-cell formation, intranuclear and cytoplasmic inclusions, dyskeratosis, spongiosis, and intracellular edema. The authors report for the first time in human a case of measles with the presence of multinucleated giant cells in the hair follicle and dyskeratosis in acrosyringium.


Subject(s)
Epidermis/pathology , Hair Follicle/pathology , Measles/pathology , Biopsy , Child , Giant Cells/pathology , Humans , Keratinocytes/pathology , Male , Parakeratosis/pathology
4.
An. bras. dermatol ; 95(2): 238-240, Mar.-Apr. 2020. graf
Article in English | LILACS, Coleciona SUS | ID: biblio-1130853

ABSTRACT

Abstract Some epidermal alterations in measles has been described, such as keratinocytes apoptotic, parakeratosis, giant-cell formation, intranuclear and cytoplasmic inclusions, dyskeratosis, spongiosis, and intracellular edema. The authors report for the first time in human a case of measles with the presence of multinucleated giant cells in the hair follicle and dyskeratosis in acrosyringium.


Subject(s)
Humans , Male , Child , Hair Follicle/pathology , Epidermis/pathology , Measles/pathology , Parakeratosis/pathology , Biopsy , Giant Cells/pathology , Keratinocytes/pathology
7.
PLoS Negl Trop Dis ; 12(2): e0006225, 2018 02.
Article in English | MEDLINE | ID: mdl-29481560

ABSTRACT

BACKGROUND: The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength of evidence from very few clinical trials and some case series reports. Current treatment guidelines recommend pentamidine isethionate or meglumine antimoniate (Glucantime) as the first-line choices. Both are parenteral drugs with a low therapeutic indexes leading to a high risk of undesired effects. Imidazole derivatives interfere with the production of leishmanial ergosterol, an essential component of their membrane structure. One drug that has been studied in different clinical presentations of Leishmania is fluconazole, a hydrophilic bis-triazole, which is easily absorbed through the oral route with a low toxicity profile and is considered safe for children. This drug is readily available in poor countries with a reasonable cost making it a potential option for treating leishmaniasis. METHODS AND FINDINGS: An adaptive nonrandomized clinical trial with sequential groups with dose escalation of oral fluconazole was designed to treat adult men with localized cutaneous leishmaniasis (LCL) in Manaus, Brazil. Eligible participants were patients with LCL with confirmed Leishmania guyanensis infection. RESULTS: Twenty adult male patients were treated with 450 mg of fluconazole daily for 30 days. One patient (5%) was cured within 30 days of treatment. Of the 19 failures (95%), 13 developed a worsening of ulcers and six evolved lymphatic spreading of the disease. Planned dose escalation was suspended after the disappointing failure rate during the first stage of the trial. CONCLUSION/SIGNIFICANCE: Oral fluconazole, at the dose of 450mg per day, was not efficacious against LCL caused by Leishmania guyanensis in adult men. TRIAL REGISTRATION: Brazilian Clinical Trial Registration (ReBec)-RBR-8w292w; UTN number-1158-2421.


Subject(s)
Antiprotozoal Agents/therapeutic use , Fluconazole/therapeutic use , Leishmania guyanensis/drug effects , Leishmaniasis, Cutaneous/drug therapy , Administration, Oral , Adolescent , Adult , Antiprotozoal Agents/administration & dosage , Brazil , Fluconazole/administration & dosage , Hand/diagnostic imaging , Hand/parasitology , Humans , Leishmania guyanensis/pathogenicity , Leishmaniasis, Cutaneous/parasitology , Leishmaniasis, Cutaneous/pathology , Male , Middle Aged , Non-Randomized Controlled Trials as Topic , Treatment Failure , Young Adult
8.
An Bras Dermatol ; 90(3 Suppl 1): 212-5, 2015.
Article in English | MEDLINE | ID: mdl-26312720

ABSTRACT

HIV/syphilis co-infection is common because both conditions affect similar risk groups. HIV interferes with the natural history of syphilis, which often has atypical clinical features and nervous system involvement in the early stage of disease. We report the case of an HIV-positive patient with secondary syphilis, scaling palmoplantar keratoderma, scrotal eczema, balanitis and urethritis mimicking Reiter's syndrome. Immunohistochemistry using polyclonal antibodies against Treponema pallidum revealed the presence of spirochetes, associated with the paretic form of parenchymal neurosyphilis. The patient was given crystalline penicillin, with complete resolution of dermatological and neurological symptoms, and no sequelae.


Subject(s)
Arthritis, Reactive/pathology , Coinfection/pathology , HIV Infections/pathology , Neurosyphilis/pathology , Adult , Anti-Bacterial Agents/therapeutic use , Biopsy , Diagnosis, Differential , Humans , Immunohistochemistry , Keratoderma, Palmoplantar/drug therapy , Keratoderma, Palmoplantar/pathology , Male , Neurosyphilis/drug therapy , Penicillin G/therapeutic use , Treatment Outcome
9.
An. bras. dermatol ; 90(3,supl.1): 212-215, May-June 2015. ilus
Article in English | LILACS | ID: lil-755786

ABSTRACT

Abstract

HIV/syphilis co-infection is common because both conditions affect similar risk groups. HIV interferes with the natural history of syphilis, which often has atypical clinical features and nervous system involvement in the early stage of disease. We report the case of an HIV-positive patient with secondary syphilis, scaling palmoplantar keratoderma, scrotal eczema, balanitis and urethritis mimicking Reiter’s syndrome. Immunohistochemistry using polyclonal antibodies against Treponema pallidum revealed the presence of spirochetes, associated with the paretic form of parenchymal neurosyphilis. The patient was given crystalline penicillin, with complete resolution of dermatological and neurological symptoms, and no sequelae.

.


Subject(s)
Adult , Humans , Male , Arthritis, Reactive/pathology , Coinfection/pathology , HIV Infections/pathology , Neurosyphilis/pathology , Anti-Bacterial Agents/therapeutic use , Biopsy , Diagnosis, Differential , Immunohistochemistry , Keratoderma, Palmoplantar/drug therapy , Keratoderma, Palmoplantar/pathology , Neurosyphilis/drug therapy , Penicillin G/therapeutic use , Treatment Outcome
10.
Ther Clin Risk Manag ; 10: 851-60, 2014.
Article in English | MEDLINE | ID: mdl-25328400

ABSTRACT

Lobomycosis is a subcutaneous mycosis of chronic evolution caused by the Lacazia loboi fungus. Its distribution is almost exclusive in the Americas, and it has a particularly high prevalence in the Amazon basin. Cases of lobomycosis have been reported only in dolphins and humans. Its prevalence is higher among men who are active in the forest, such as rubber tappers, bushmen, miners, and Indian men. It is recognized that the traumatic implantation of the fungus on the skin is the route by which humans acquire this infection. The lesions affect mainly exposed areas such as the auricles and upper and lower limbs and are typically presented as keloid-like lesions. Currently, surgical removal is the therapeutic procedure of choice in initial cases. Despite the existing data and studies to date, the active immune mechanisms in this infection and its involvement in the control or development of lacaziosis have not been fully clarified. In recent years, little progress has been made in the appraisal of the epidemiologic aspects of the disease. So far, we have neither a population-based study nor any evaluation directed to the forest workers.

11.
An Bras Dermatol ; 89(5): 816-8, 2014.
Article in English | MEDLINE | ID: mdl-25184926

ABSTRACT

Synovial sarcomas are rare malignant tumors affecting mainly young adults, presenting as a slow growth mass located in deep soft tissues of extremities, near the joints. In this report a 34-year-old male patient, presented an ulcerovegetative lesion on the right wrist which was completely excised. Histopathology and immunohistochemistry confirmed synovial sarcomas with poorly differentiated cells. This patient presented 11 months later with ipsilateral axillary lymph node metastasis, which emphasizes the unfavorable prognosis of this synovial sarcoma variant. The indolent growth pattern of this sarcoma justifies the well circumscribed initial stages, which progressively infiltrate adjacent structures with lung metastasis (80%) and lymph node involvement (20%) and thus corroborates the importance of early diagnosis and proper treatment.


Subject(s)
Sarcoma, Synovial/pathology , Skin/pathology , Soft Tissue Neoplasms/pathology , Wrist , Adult , Biopsy , Humans , Immunohistochemistry , Male
12.
An. bras. dermatol ; 89(5): 816-818, Sep-Oct/2014. graf
Article in English | LILACS | ID: lil-720780

ABSTRACT

Synovial sarcomas are rare malignant tumors affecting mainly young adults, presenting as a slow growth mass located in deep soft tissues of extremities, near the joints. In this report a 34-year-old male patient, presented an ulcerovegetative lesion on the right wrist which was completely excised. Histopathology and immunohistochemistry confirmed synovial sarcomas with poorly differentiated cells. This patient presented 11 months later with ipsilateral axillary lymph node metastasis, which emphasizes the unfavorable prognosis of this synovial sarcoma variant. The indolent growth pattern of this sarcoma justifies the well circumscribed initial stages, which progressively infiltrate adjacent structures with lung metastasis (80%) and lymph node involvement (20%) and thus corroborates the importance of early diagnosis and proper treatment.


Subject(s)
Adult , Humans , Male , Sarcoma, Synovial/pathology , Skin/pathology , Soft Tissue Neoplasms/pathology , Wrist , Biopsy , Immunohistochemistry
13.
An Bras Dermatol ; 89(2): 351-2, 2014.
Article in English | MEDLINE | ID: mdl-24770521

ABSTRACT

Chromoblastomycosis is a chronic subcutaneous mycotic infection caused by dematiaceous saprophytic moulds. The most frequently isolated agent is Fonsecae pedrosoi. This article reports a case of a man from the Amazon region in Northern Brazil who presented with a lesion of 12 months' duration, which gradually increased in size until covering the majority of his right leg. A successful treatment with itraconazole was performed.


Subject(s)
Chromoblastomycosis/pathology , Fungi, Unclassified , Antifungal Agents/therapeutic use , Brazil , Chromoblastomycosis/drug therapy , Humans , Itraconazole/therapeutic use , Male , Middle Aged , Treatment Outcome
14.
An. bras. dermatol ; 89(2): 351-352, Mar-Apr/2014. graf
Article in English | LILACS | ID: lil-706991

ABSTRACT

Chromoblastomycosis is a chronic subcutaneous mycotic infection caused by dematiaceous saprophytic moulds. The most frequently isolated agent is Fonsecae pedrosoi. This article reports a case of a man from the Amazon region in Northern Brazil who presented with a lesion of 12 months' duration, which gradually increased in size until covering the majority of his right leg. A successful treatment with itraconazole was performed.


Subject(s)
Humans , Male , Middle Aged , Chromoblastomycosis/pathology , Fungi, Unclassified , Brazil , Chromoblastomycosis/drug therapy , Treatment Outcome , Itraconazole/therapeutic use , Antifungal Agents/therapeutic use
16.
Clin Microbiol Rev ; 25(1): 79-105, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22232372

ABSTRACT

Myiasis is defined as the infestation of live vertebrates (humans and/or animals) with dipterous larvae. In mammals (including humans), dipterous larvae can feed on the host's living or dead tissue, liquid body substance, or ingested food and cause a broad range of infestations depending on the body location and the relationship of the larvae with the host. In this review, we deeply discuss myiasis as a worldwide infestation with different agents and with its broad scenario of clinical manifestations as well as diagnosis techniques and treatment.


Subject(s)
Diptera/pathogenicity , Myiasis/epidemiology , Myiasis/pathology , Animals , Antiparasitic Agents/therapeutic use , General Surgery/methods , Humans , Mammals , Myiasis/parasitology , Myiasis/therapy
17.
Surg. cosmet. dermatol. (Impr.) ; 3(4): 355-357, dez. 2011. ilus
Article in English, Portuguese | LILACS-Express | LILACS | ID: lil-684935

ABSTRACT

Paciente do sexo masculino, 54 anos de idade com diagnóstico de tumor triquilemal gigante recidivante localizado no dorso, com cirurgia prévia realizada há seis anos. Após exérese da lesão com margem de 1cm, foi realizada reconstrução com retalho miocutâneo bilateral do músculo grande dorsal, com fechamento da ferida operatória. Descrevemos neste relato características clinicoepidemiológicas do tumor triquilemal, assim como as opções terapêuticas.


This article reports the case of a 54-year-old male patient diagnosed with a recurrent gigantic trichilemmal tumor on the back, having undergone surgery six years earlier. After the exeresis of the lesion (with 1 cm margins), econstruction was carried out using a bilateral myocutaneous flap from the latissimus dorsi muscle to close the surgical wound. This report describes the clinical-epidemic characteristics of trichilemmal tumors, as well as treatment options.

18.
An Bras Dermatol ; 86(4 Suppl 1): S31-4, 2011.
Article in English, Portuguese | MEDLINE | ID: mdl-22068765

ABSTRACT

Exogenous ochronosis consists of chronic hyperpigmentation of areas previously treated with topical agents such as hydroquinone, resorcinol, antimalarials and phenol. Early diagnosis allows to promptly suspend the causative agent and it is imperative since the available therapeutic options are scarce and have presented so far unsatisfactory results. Three cases of exogenous ochronosis on the face which were diagnosed with the use of dermoscopy are presented. Dermatoscopy showed blackish-gray amorphous structures, some obliterating the follicular openings. Histopathological examination confirmed the diagnosis.


Subject(s)
Dermatologic Agents/adverse effects , Dermoscopy , Facial Dermatoses/chemically induced , Hydroquinones/adverse effects , Ochronosis/chemically induced , Adult , Facial Dermatoses/diagnosis , Female , Humans , Hyperpigmentation/diagnosis , Middle Aged , Ochronosis/diagnosis
19.
An. bras. dermatol ; 86(4,supl.1): 31-34, jul,-ago. 2011. ilus
Article in Portuguese | LILACS | ID: lil-604114

ABSTRACT

A ocronose exógena consiste em hiperpigmentação crônica de áreas previamente tratadas com agentes tópicos como: a hidroquinona, a resorcina, os antimaláricos e o fenol. O diagnóstico precoce permite suspender prontamente o agente causador, uma vez que as opções terapêuticas disponíveis são escassas e com resultados insatisfatórios. Reportam-se três casos de ocronose exógena na face, diagnosticados pela dermatoscopia. O estudo dermatoscópico evidenciou estruturas amorfas de coloração cinza-enegrecido, algumas obliterando as aberturas foliculares. O exame histopatológico corroborou o diagnóstico.


Exogenous ochronosis consists of chronic hyperpigmentation of areas previously treated with topical agents such as hydroquinone, resorcinol, antimalarials and phenol. Early diagnosis allows to promptly suspend the causative agent and it is imperative since the available therapeutic options are scarce and have presented so far unsatisfactory results. Three cases of exogenous ochronosis on the face which were diagnosed with the use of dermoscopy are presented. Dermatoscopy showed blackish-gray amorphous structures, some obliterating the follicular openings. Histopathological examination confirmed the diagnosis.


Subject(s)
Adult , Female , Humans , Middle Aged , Dermoscopy , Dermatologic Agents/adverse effects , Facial Dermatoses/chemically induced , Hydroquinones/adverse effects , Ochronosis/chemically induced , Facial Dermatoses/diagnosis , Hyperpigmentation/diagnosis , Ochronosis/diagnosis
20.
Rev Soc Bras Med Trop ; 44(1): 22-5, 2011.
Article in English | MEDLINE | ID: mdl-21340402

ABSTRACT

INTRODUCTION: Neuroparacoccidioidomycosis (NPCM) is a term used to describe the invasion of the central nervous system by the pathogenic fungus Paracoccidioides brasiliensis. NPCM has been described sporadically in some case reports and small case series, with little or no focus on treatment outcome and long-term follow-up. METHODS: All patients with NPCM from January 1991 to December 2006 were analyzed and were followed until December 2009. RESULTS: Fourteen (3.8%) cases of NPCM were identified out of 367 patients with paracoccidioidomycosis (PCM). A combination of oral fluconazole and sulfamethoxazole/trimethoprim (SMZ/TMP) was the regimen of choice, with no documented death due to Paracoccidioides brasiliensis infection. Residual neurological deficits were observed in 8 patients. Residual calcification was a common finding in neuroimaging follow-up. CONCLUSIONS: All the patients in this study responded positively to the association of oral fluconazole and sulfamethoxazole/trimethoprim, a regimen that should be considered a treatment option in cases of NPCM. Neurological sequela was a relatively common finding. For proper management of these patients, anticonvulsant treatment and physical therapy support were also needed.


Subject(s)
Antifungal Agents/therapeutic use , Central Nervous System Fungal Infections/drug therapy , Fluconazole/therapeutic use , Paracoccidioidomycosis/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Adult , Central Nervous System Fungal Infections/microbiology , Female , Follow-Up Studies , Humans , Middle Aged , Paracoccidioidomycosis/microbiology , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...